RxDoctor Payments Data

Elizabeth Degrush, DO

Psychiatry · Westborough, MANPI 1669767539

Payments from drug & device makers

$5,501in general payments, 2019–2025

Across 317 payments — averaging $17.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$377
  • Pfizer$375
  • Supernus Pharmaceuticals, Inc.$361
  • Amgen$184
  • Amneal Pharmaceuticals LLC$125
  • plus $2K from 36 others

What the payments were for

  • Speaking & faculty fees$801%
  • Food & beverage$5,31297%
  • Education$1092%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,501 in reported general payments places this provider in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$96,777
Medicare patients
199
Services billed
762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine17$116,827
VraylarCariprazine Hcl43$79,423
QuliptaAtogepant23$48,930
UbrelvyUbrogepant22$23,168
BriviactBrivaracetam15$20,510
NuedextaDextromethorphan Hbr/Quinidine12$18,290
Lamotrigine ErLamotrigine48$16,100
VyvanseLisdexamfetamine Dimesylate24$10,306
Aimovig AutoinjectorErenumab-Aooe11$8,179
Lurasidone Hcl22$5,607
Desvenlafaxine Succinate ErDesvenlafaxine Succinate30$5,507
Buspirone Hcl151$5,078
Atomoxetine Hcl21$5,053
Adderall XrDextroamphetamine/Amphetamine14$4,734
Divalproex Sodium54$4,510

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Qulipta, Ubrelvy$2,046$151,52188 claims
Teva Pharmaceuticals USA, Inc.Austedo$377$116,82717 claims
UCB, Inc.Briviact$124$20,51015 claims
Avanir Pharmaceuticals, Inc.Nuedexta$65$18,29012 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$47$10,30624 claims
Upsher-smith Laboratories LLCTopiramate$30$1,34670 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Westborough

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →